Vera Therapeutics (VERA) Interest & Investment Income (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Interest & Investment Income came in at $6.4 million in Q1 2026, down 7.98% YoY from $6.9 million in Q1 2025, and up 15.19% on a QoQ basis from $5.5 million in Q4 2025.
Vera Therapeutics (VERA) Interest & Investment Income (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of Interest & Investment Income data on file, last reported at $6.4 million in Q1 2026.
- Quarterly Interest & Investment Income fell 7.98% year-over-year to $6.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.9 million (up 2.11% YoY) and the FY2025 annual result came in at $24.5 million, up 18.18% from the prior year.
- Interest & Investment Income improved to $6.4 million in Q1 2026, from $5.5 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $6.9 million in Q1 2025 to a low of $26000.0 in Q1 2022.
- A 5-year average of $3.6 million and a median of $4.2 million in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 14800.0% — and 2025, when it retreated 17.2%.
- Tracing VERA's Interest & Investment Income over 5 years: stood at $894000.0 in 2022, then surged by 119.24% to $2.0 million in 2023, then soared by 239.95% to $6.7 million in 2024, then dropped by 17.2% to $5.5 million in 2025, then climbed by 15.19% to $6.4 million in 2026.
- The last three Interest & Investment Income figures came in at $6.4 million (Q1 2026), $5.5 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | 5.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.35 Mn |
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Jun 30, 2025 | 6.32 Mn |
| Mar 31, 2025 | 6.91 Mn |
| Dec 31, 2024 | 6.66 Mn |
| Sep 30, 2024 | 4.76 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Sep 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 894,000.00 |
| Sep 30, 2022 | 567,000.00 |
| Jun 30, 2022 | 263,000.00 |
| Mar 31, 2022 | 26,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 5,000.00 |